Farid Ramy 4
4 · Schrodinger, Inc. · Filed Apr 17, 2026
Research Summary
AI-generated summary of this filing
Schrödinger (SDGR) CEO Farid Ramy Exercises Options, Sells Shares
What Happened
Farid Ramy, President & CEO and director of Schrödinger, exercised stock options and sold a portion of the resulting shares. He acquired 160,527 shares via option exercises (three exercises at a $3.07 exercise price) for a total cash outlay of $492,818, and sold 86,000 shares in open-market transactions for aggregate proceeds of about $1,055,177. The pattern — exercise at $3.07 and near-immediate sales at ~ $12.2–$12.3 — is consistent with exercising and selling shares (cashless/same-day dispositions).
Key Details
- Transaction dates: April 16–17, 2026. Form filed April 17, 2026. No late filing is indicated in the Form 4.
- Exercises (acquisitions): 160,527 shares total
- 4/16: 43,000 shares @ $3.07 = $132,010
- 4/17: 43,000 shares @ $3.07 = $132,010
- 4/17: 74,527 shares @ $3.07 = $228,798
- Total paid ≈ $492,818
- Sales (dispositions): 86,000 shares total
- 4/16: 43,000 shares, weighted avg $12.33, proceeds $530,233 (sales priced between $11.80–$12.79 per footnote)
- 4/17: 43,000 shares, weighted avg $12.21, proceeds $524,944 (sales priced between $11.66–$12.49 per footnote)
- Total proceeds ≈ $1,055,177
- Filing footnotes:
- F1: Transactions effected under a Rule 10b5‑1 trading plan adopted Sept 2, 2025.
- F2/F3: Reported sale prices are weighted averages; detailed per-price breakdowns available on request.
- F4: Holdings disclosure includes 132,634 unvested RSUs.
- F5: The option exercised (part of transactions) was granted May 11, 2016 and is fully vested.
- Shares owned after the reported transactions: not specified in the filing (the Form 4 lists holdings components including the unvested RSUs above).
Context
- The filing shows option exercises followed by open-market sales; lines showing derivative “disposed” at $0 reflect conversion/exercise mechanics rather than additional cash sales. This is a routine insider liquidity event, and the trades were done under a pre-established 10b5‑1 plan. As always, sales do not necessarily indicate a CEO’s view of company prospects; purchases are generally considered a stronger positive signal.
Insider Transaction Report
- Exercise/Conversion
Common Stock
[F1]2026-04-16$3.07/sh+43,000$132,010→ 373,824 total - Sale
Common Stock
[F1][F2]2026-04-16$12.33/sh−43,000$530,233→ 330,824 total - Exercise/Conversion
Common Stock
[F1]2026-04-17$3.07/sh+43,000$132,010→ 373,824 total - Sale
Common Stock
[F1][F3]2026-04-17$12.21/sh−43,000$524,944→ 330,824 total - Exercise/Conversion
Common Stock
[F4]2026-04-17$3.07/sh+74,527$228,798→ 405,351 total - Exercise/Conversion
Stock Option (right to buy)
[F1][F5]2026-04-16−43,000→ 117,527 totalExercise: $3.07Exp: 2026-05-10→ Common Stock (43,000 underlying) - Exercise/Conversion
Stock Option (right to buy)
[F1][F5]2026-04-17−43,000→ 74,527 totalExercise: $3.07Exp: 2026-05-10→ Common Stock (43,000 underlying) - Exercise/Conversion
Stock Option (right to buy)
[F5]2026-04-17−74,527→ 0 totalExercise: $3.07Exp: 2026-05-10→ Common Stock (74,527 underlying)
Footnotes (5)
- [F1]These transactions were effected pursuant to a Rule 10b5-1 trading plan adopted by the reporting person on September 2, 2025.
- [F2]The price reported in Column 4 is a weighted average price. These shares were sold in multiple transactions at prices ranging from $11.80 to $12.79, inclusive. The reporting person undertakes to provide to the Issuer, any security holder of the Issuer, or the staff of the U.S. Securities and Exchange Commission, upon request, full information regarding the number of shares sold at each separate price within the ranges set forth in this footnote(2) of this Form 4.
- [F3]The price reported in Column 4 is a weighted average price. These shares were sold in multiple transactions at prices ranging from $11.66 to $12.49, inclusive. The reporting person undertakes to provide to the Issuer, any security holder of the Issuer, or the staff of the U.S. Securities and Exchange Commission, upon request, full information regarding the number of shares sold at each separate price within the ranges set forth in this footnote(3) of this Form 4.
- [F4]Includes 132,634 unvested RSUs.
- [F5]The option was granted on May 11, 2016 and is fully vested.